Physician profile
Caroline Olvera
NPI 1639531817
$1,875.01
in general payments reported to CMS, 2019-2025
7 companies · $1,520 in 2025
The $1,520 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2022: $15.99 · 2023: $43.64 · 2024: $40.19 · 2025: $1,520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911 · Travel and Lodging: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $911.46 |
| Travel and Lodging | $692.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Onmark, INC. | $1,341.22 | 2025 | |
| Genentech USA, INC. | $255.21 | 2019 | |
| Aucta Pharmaceuticals, INC. | $150.18 | 2025 | Motpoly Xr |
| Biogen, INC. | $43.64 | 2023 | Vumerity, Tysabri |
| Abbvie INC. | $34.61 | 2022-2024 | |
| Ipsen Biopharmaceuticals, INC | $28.58 | 2025 | Dysport |
| Alexion Pharmaceuticals, INC. | $21.57 | 2024 | Soliris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Olvera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.